- NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
- NanoVibronix Issues Letter to Stockholders
- NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
- NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
- NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
More ▼
Key statistics
On Thursday, Nanovibronix Inc (NAOV:NAQ) closed at 0.745, 9.96% above its 52-week low of 0.6775, set on May 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.74 |
---|---|
High | 0.805 |
Low | 0.74 |
Bid | 0.7311 |
Offer | 0.77 |
Previous close | 0.745 |
Average volume | 30.33k |
---|---|
Shares outstanding | 2.78m |
Free float | 2.77m |
P/E (TTM) | -- |
Market cap | 2.07m USD |
EPS (TTM) | -1.72 USD |
Data delayed at least 15 minutes, as of May 23 2024 21:00 BST.
More ▼